ArticleOncoimmunology2023

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.

Annalisa Adamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.